In a recent early-phase trial, treatment with raludotatug deruxtecan (R-DXd) has shown to lead to an “exciting” response rate among patients with heavily pretreated, platinum-resistant advanced ovarian cancer. An antibody drug conjugate (ADC) directed against cadherin 6 (CDH6), R-DXd resulted in one complete response and 17 partial responses among 37 evaluable patients, with an overall
Health
It is evident that the recent decision by the CDC to reduce the isolation time for COVID-19 from 5 days to 24 hours has raised serious concerns among healthcare workers, particularly nurses. National Nurses United (NNU) had previously expressed their worries regarding the weakening of isolation guidance for COVID-19, considering the potential risks associated with
Neurological disorders have emerged as the leading cause of ill health and disability worldwide, affecting a staggering 3.4 billion people according to the Global Burden of Disease (GBD) Study. This systematic analysis revealed that neurologic conditions impacted 43.1% of the global population, surpassing cardiovascular diseases to become the primary contributor to the global disease burden
Recent data from the National Inpatient Sample (NIS) has revealed a concerning trend in the American West – a significant surge in hospital admissions for cardiomyopathy among methamphetamine users. This article will delve into the details of this study, analyzing the demographic and regional disparities highlighted by the researchers. According to the study, methamphetamine-related cardiomyopathy
Space travel has long been a fascination for many, but recent studies have shed light on the potentially negative impacts it may have on the human body. A prospective study conducted on astronauts who participated in long-haul space flights revealed some startling findings regarding headaches experienced during their missions. The research, led by Willebrordus P.
The recent findings of an observational Swedish study on patients with attention-deficit/hyperactivity disorder (ADHD) have shed light on the potential association between starting medication and a lower risk of mortality, particularly from “unnatural” causes. These results have significant implications for the treatment of individuals with ADHD, as timely diagnosis and pharmacological intervention could potentially reduce
Amyotrophic lateral sclerosis (ALS) patients like Grace Armant face significant challenges when seeking coverage for the home ventilators they need to breathe. Insurance companies, including UnitedHealthcare, have been rejecting requests for these life-saving machines. This refusal puts patients at risk and forces them to deal with less effective devices initially to prove necessity. The demand
Richard Lowenthal, president and CEO of ARS Pharmaceuticals, shed light on the importance of testing intranasal epinephrine spray ARS-1 (also known as neffy) under extreme temperatures. The concerns raised by parents about leaving the EpiPen in the car and throwing it away due to fears of it getting hot highlighted the need for such testing.
The financial success of UnitedHealth Group (UHG) is staggering, with revenue reaching nearly $400 billion in 2023. This massive empire, fueled by profits of $22.4 billion, has raised concerns about the implications of its dominance in the healthcare industry. Through vertical integration and acquisitions like Optum, UHG has established a value-chain monopoly, controlling everything from
